Latest Breaking News On - Lexicon pharmaceuticals daily - Page 1 : comparemela.com

Lexicon Pharmaceuticals (NASDAQ:LXRX) Lifted to Sell at StockNews com

Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) was upgraded by StockNews.com to a “sell” rating in a research report issued on Thursday. Several other analysts have also commented on LXRX. Leerink Partnrs reiterated an “outperform” rating on shares of Lexicon Pharmaceuticals in a report on Tuesday, April 30th. Needham & Company LLC reissued a “hold” […]

Leerink partnrsLexicon pharmaceuticals incPrincipal securities incSwiss national bankChina universal asset management coNews ratings for lexicon pharmaceuticals dailyVictory capital management incInstitutional investors weigh in on lexicon pharmaceuticalsLexicon pharmaceuticals stock downLexicon pharmaceuticalsNeedham companyGet free reportPharmaceuticals stock downNational bankUniversal asset managementCapital management

Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX) Sees Large Growth in Short Interest

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 23,440,000 shares, a growth of 16.5% from the April 15th total of 20,120,000 shares. Based on an average daily volume of 4,450,000 shares, […]

Leerink partnrsCantor fitzgeraldLexicon pharmaceuticalsPrincipal securities incCommonwealth equity servicesNeedham companyHedge funds weigh in on lexicon pharmaceuticalsNational associationLexicon pharmaceuticals incChina universal asset management coLexicon pharmaceuticals company profileLexicon pharmaceuticals stockNews ratings for lexicon pharmaceuticals dailyGet free reportEquity servicesChina universal asset management

Lexicon Pharmaceuticals (NASDAQ:LXRX) Earns Hold Rating from Needham & Company LLC

Lexicon Pharmaceuticals (NASDAQ:LXRX) Earns Hold Rating from Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cantor fitzgeraldLeerink partnrsLexicon pharmaceuticalsLexicon pharmaceuticals incNeedham companyLexicon pharmaceuticals stockPrincipal securities incChina universal asset management coInstitutional trading of lexicon pharmaceuticalsCommonwealth equity servicesNational associationNews ratings for lexicon pharmaceuticals dailyFree reportGet free reportEquity servicesChina universal asset management

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Rating Reaffirmed by Needham & Company LLC

Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Rating Reaffirmed by Needham & Company LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Leerink partnrsLexicon pharmaceuticalsLexicon pharmaceuticals incSwiss national bankNeedham companyHedge funds weigh in on lexicon pharmaceuticalsSg americas securitiesCommonwealth equity servicesNational associationNews ratings for lexicon pharmaceuticals dailyLexicon pharmaceuticals tradingFree reportGet free reportEquity servicesNational bankLexicon pharmaceuticals daily

Lexicon Pharmaceuticals (NASDAQ:LXRX) Upgraded at StockNews com

Lexicon Pharmaceuticals (NASDAQ:LXRX) Upgraded at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cantor fitzgeraldNeedham companyPrincipal securities incLexicon pharmaceuticals incNational associationLexicon pharmaceuticals stock performanceInstitutional trading of lexicon pharmaceuticalsNews ratings for lexicon pharmaceuticals dailyLexicon pharmaceuticalsChina universal asset management coFree reportGet free reportUniversal asset managementLexicon pharmaceuticals daily